SUPPRESSION OF URIC ACID SYNTHESIS IN THE GOUTY HUMAN BY THE USE OF 6-DIAZO-5-OXO-L-NORLEUCINE

Documenti analoghi

• 6-Diazo-5-Oxo-l-Norleucine Inhibition of Escherichia coli
  di: Coggin, J. H., et al.
  Pubblicazione: (1965)
• Evaluating the Analgesic Effect of the GLS Inhibitor 6-Diazo-5-Oxo-L-Norleucine in Vivo
  di: Crosby, Heith A, et al.
  Pubblicazione: (2016)
• Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy
  di: Cervantes-Madrid, Diana, et al.
  Pubblicazione: (2015)
• Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis
  di: Manivannan, Sivabalan, et al.
  Pubblicazione: (2016)
• We’re Not “DON” Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine
  di: Lemberg, Kathryn M., et al.
  Pubblicazione: (2018)